In addition to Alzheimer’s disease, ApoE has been implicated in other diseases such as parkinsonism (Jellinger, 2018) and HIV-related dementia (Olivier et al., 2018), further highlighting SELENOP1-ApoER2 interaction as an area of interest in neurodegeneration research. This evidence concerns the gene LRP8 and early-onset autosomal dominant Alzheimer disease.